$Hims & Hers Health(HIMS.US)According to the latest data (as of December 2025), the equity structure of Hims & Hers Health (HIMS) shows a "institution-dominated, concentrated executive ownership" characteristic.

Below is a detailed breakdown of the shareholding situation:

📊 1. Institutional Investors (Majority)

Institutions are the absolute main force of HIMS. According to the latest disclosure data from Tencent Securities and Tonghuashun, the major institutional holdings are as follows:

BlackRock (BlackRock) ~25.146 million shares 11.05% Increased (Q4)

The Vanguard Group (Vanguard) ~19.518 million shares 8.57% Increased (Q4)

Capital Research (Capital Group) ~18.783 million shares 8.25% Increased (Q4)

JP Morgan Asset Management ~13.056 million shares 5.74% Significantly increased

* Trend analysis: Global top asset management giants have recently increased their holdings, which is usually seen as institutional recognition of HIMS's long-term fundamentals.

👥 2. Insiders (Executives & Founders)

Insider holdings are relatively concentrated, mainly in the hands of the founder and CEO.

* Andrew Dudum (CEO/Founder):

* Shares held: ~17.474 million shares.

* Shareholding ratio: ~7.68%.

* Note: He holds the most shares among insiders and recently made a small reduction (-236.6k shares), which may be related to personal tax or asset allocation, but his overall position remains heavy.

🧩 3. Full Equity Structure (Total)

Combined with the previous total share capital data (~228 million shares), the current equity distribution is roughly as follows:

* Institutional holdings: Extremely high, estimated to account for 80%-90%+ of the total shares.

* Insider holdings: ~7-8% (mainly CEO Andrew Dudum).

* Public float: The remaining portion is held by retail investors, with a relatively small proportion.